Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase

By Yoshikawa T.   Suzuki Y.   Nomoto A.   Sata T.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 60-66

Elsevier

Access to resources Recommend Favorite

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

By Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 899-906

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

By Minutello M.   Senatore F.   Cecchinelli G.   Bianchi M.   Andreani T.   Podda A.   Crovari P.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Antibody responses and protection in mice immunized orally against influenza virus

By Takase H.   Murakami Y.   Endo A.   Ikeuchi T.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1651-1656

Elsevier

Access to resources Recommend Favorite

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes

By Van Reeth K.   Gregory V.   Hay A.   Pensaert M.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1375-1381

Elsevier

Access to resources Recommend Favorite